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I. INTRODUCTION
“Instead of walking down the aisle before a bride. I walked behind a casket,”
wept Mary Jo Linnen, mother of a thirty-year-old woman who died in February 1997
of a heart and lung disorder after taking the prescription “drug cocktail,” fen-phen to
lose a few pounds before her wedding.1
Unfortunately, dieters experienced an array of negative side effects from taking
fen-phen before the diet drug pair, a combination of fenfluramine (brand name
Pondimin) and phentermine (brand name Redux), was voluntarily removed from the
market upon the Food and Drug Administration’s (FDA) request.2 Although the
FDA did not approve this simultaneous, off-label use3 of these two drugs, doctors
prescribed the mixture millions of times each year.4
Weight conscious consumers have flocked to various brands of “herbal fen-phen”
since the withdrawal of prescription fen-phen.5 These herbal alternatives do not
contain the prescription drugs fenfluramine or phentermine;6 consequently,
consumers can browse the aisles of a health food store and choose from numerous
versions of herbal fen-phen type products that all promise the same results.7
However, the dangerous reality is that these products have not been proven safe and
effective.8 Legislation currently governing dietary supplements is dangerously
inadequate. Specifically, the Dietary Supplement Health and Education Act of 1994

1

Woman's Death Raises Questions About Fen-Phen Diet, NANDO NET (May 6, 1997)
<http://pharminfo.com/drugdb/dbgn_mnua.html>. Mary Linnen certainly was not obese at
5’6” and 185-190 pounds. Id. Before her untimely death, drug manufacturers warned doctors
that the off-label combination of the two fen-phen drugs was neither safe nor recommended
for her weight loss goals; therefore, her physician should not have prescribed fen-phen in this
instance. Id.
2

Id.; FOOD AND DRUG ADMINISTRATION, FDA Warns Against Drug Promotion of “Herbal
Fen-Phen,” FDA TALK PAPER (Nov. 6, 1997) <http://www.fda.gov/bbs/topics/
ANSWERS/ANS00832.html> [hereinafter FDA Warns]. Fenfluramine is a European weight
loss drug that acts on both serotonin and dopamine levels in the human body. Michael D.
LeMonick et al., Medicine: The Mood Molecule Serotonin Drugs Treat Everything from
Depression to Overeating, But as We Learned Last Week, Tinkering with the Chemistry of the
Brain Can Be Risky, TIME MAG., Sept. 29, 1997, available in 1997 WL 13375884. Because it
also put dieters to sleep, it was linked with phentermine. Id. Phentermine is an amphetamine
like drug, boosting alertness and the metabolism. Id.
3

LeMonick et al., supra note 2.

4

See Woman’s Death Raises Questions About Fen-Phen Diet, supra note 1.

5

See FDA Warns, supra note 2.

6

TrendMark Thin-Thin Diet Program Weight Loss Claims Lack Substantiation, TAN
SHEET, June 29, 1998, available in 1998 WL 8449577.
7

FOOD AND DRUG ADMINISTRATION, Warning About Herbal Fen-Phen, FDA CONSUMER
MAG., (Jan.-Feb. 1998) <http://vm.cfsan.fda.gov/~dms/fdsupp.html> [hereinafter Warning
About Herbal Fen-Phen].
8

Id.; U.S. Government Warns Consumers About ‘Fen-Phen’ Substitutes, DOW JONES NEWS
SERVICE, Nov. 7, 1997, available in 11/7/97 WL-DJNS.
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(DSHEA)9 reaffirms that dietary supplements are to be classified as foods.10 This
classification does not provide enough protection for consumers in relation to herbal
fen-phen products.
Furthermore under the DSHEA, the FDA cannot even require manufacturers to
test herbal products before sold for safety or efficacy,11 rather individual
manufacturers may decide what is necessary to provide “reasonable assurance” of a
products’ safety.12 The FDA Secretary, based on limited powers granted by the
DSHEA, may remove a dangerous or adulterated supplement only when it poses an
“imminent hazard to public health or safety.”13 Such action is simply too little too
late in most instances.
This Note will examine the dangers associated with current dietary supplement
regulation under the DSHEA14 and the problem of ill-informed consumers.15 As
reflected in the title of this Note, misconceptions about dietary supplement regulation
are abundant; consequently, section II of this Note will further discuss and offer
illustrations in support of this position. Part III gives an overview of current
regulation under the Dietary Supplement Health and Education Act of 1994. Also a
brief discussion of the legislation that preceded the DSHEA is offered in section VI.
Part V of this Note analyzes and defines the dietary ingredients that are often
found in herbal fen-phen products. Specifically, this section discusses the dangerous
and unsubstantiated claims associated with these supplements.
Part V concludes by contrasting prescription fen-phen with herbal fen-phen to
explain the dangers associated with both and the dire need for prompt action to
protect consumers from “herbal” substitutes.
Part VI offers concrete proposals for dealing with inadequate regulations, which
this Note maintains are threatening consumers’ health. Finally, remedies such as
legislative amendment and increased funding for training, research, and consumer
awareness efforts will be further explored.
In the Fall of 1997, the FDA did warn consumers about the dangers related to
herbal fen-phen;16 however, since then nothing concrete has been done to put a stop
to the sale of these menacing supplements. The FDA noted that products, which are

9
Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417, 108 Stat.
4325 (1994) (codified at 21 U.S.C. § 342).
10

Id. § 3, 108 Stat. at 4327-28 (codified at 21 U.S.C. § 321(ff)).

11
Herbal Hope or Herbal Hype?, CURRENT HEALTH 2, Oct. 1, 1998, available in 1998
WL 9587086.
12

§ 4, 108 Stat. at 4328 (codified at 21 U.S.C. § 342(f)(1)(B)); Herbal Hope or Herbal
Hype?, supra note 11; Pat Kendall, Ph.D., R.D., Herbal Fen-Phen: Buyer Beware, (Oct. 15,
1997) <http://www.colostate.edu/depts/CoopExt/PUBS/ COLUMNNN/nn971015.htm>.
13

Pub. L. No. 103-417, § 4, 108 Stat. at 4328 (codified at 21 U.S.C. § 321(f)(1)(C)).

14

Pub. L. No. 103-417, 108 Stat. 4325; Mark A. Kassel, From a History of Near Misses:
The Future of Dietary Supplement Regulation, 49 FOOD & DRUG L.J. 237, 239 (1994). See
discussion infra Part III.
15

See discussion infra Parts II,VI.B.

16

Warning About Herbal Fen-Phen, supra note 7.
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intended to be used as alternatives to prescription drugs, require FDA approval
before being made available to consumers.17 The FDA stated that herbal fen-phen
products are indeed marketed as drug alternatives to prescription anti-obesity drugs.18
Companies that market or imply weight-loss benefits by imitating prescription drug
names are violating federal law and must be stopped.19
Ultimately, products like these run the risk of being classified as new drugs,
requiring FDA approval before sale.20 The FDA, using the powers earlier mentioned
that are designated by the DSHEA to its Secretary, should promptly act to change the
current availability of such products to avoid catastrophic health problems.21
Because of the leniency fostered by the DSHEA, some available herbal
alternatives contain various dietary ingredients that are dangerous and even deadly.22
Many herbal fen-phen products contain ephedrine (also known as ephedra or ma
huang) and St. John’s Wort (also known as hypericum perforatum or “herbal
Prozac”).23 In addition to a lack of evidence supporting manufacturer's claims, these
dietary ingredients combined may also pose a serious health threat to many
uninformed or careless consumers.24
II. MISCONCEPTIONS ABOUT DIETARY SUPPLEMENT REGULATION
The $6.5 billion dietary supplement market evidences American's concern with
maintaining and improving their overall health.25 A significant and growing portion
of that figure can be attributed to herbal weight-loss products, such as herbal fenphen products.26 These herbal weight-loss products have become more popular since

17
Id. “While the FDA has maintained and progressively tightened its hold over the
regulation of drugs throughout this century, the same cannot be said of the FDA’s supervision
of dietary supplements. Dietary supplements have never had a consistent classification,
bouncing around from a drug to a food additive to their present classification as a dietary
supplement. Due to Congress’s reluctance to recognize dietary supplements as potentially
dangerous or to give the FDA the power to ensure the safety of these products, manufacturers
are more likely to engage in unscrupulous and hazardous practices.” Bruce H. Schendler,
Note, Where There’s Smoke There’s Fire: The Dangers of the Unregulated Dietary
Supplement Industry, 42 N.Y.L. SCH. L. REV. 261, 266 nn.65-72 (1998).
18

Warning About Herbal Fen-Phen, supra note 7.

19

U.S. Government Warns Consumers About ‘Fen-Phen’ Substitutes, supra note 8.

20

Id.

21

Pub. L. No. 103-417, § 4, 108 Stat. at 4328 (codified at 21 U.S.C. § 342 (f)(1), (2)).

22

LeMonick et al., supra note 2.

23

Id.

24

FDA Warns, supra note 2.

25

Kristine Brenneman, Adding a Dose of Concern: Safety of Herbal Supplements
Questioned, PATRIOT LEDGER, Jan. 15, 1999, available in 1999 WL 8449241; Paula Kurtzweil,
An FDA Guide to Dietary Supplements, FDA CONSUMER MAG. (Sept.-Oct. 1998)
<http://vm.cfsan.fda.gov/~dms/fdsupp.html>.
26
U.S. DEPARTMENT
Fenfluramine
and

HEALTH AND HUMAN SERVICES, FDA Announces Withdrawal of
Dexfenfluramine,
HHS
NEWS,
(Sept.
15,
1997)

OF
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drug manufacturers followed the FDA's admonition in 1997 and removed these
prescription diet drugs from the market.27 Although dieters are eager to shed pounds
and continue to rely on promises of quick results from herbal diet remedies, the FDA
and nutritionists maintain that there is no evidence that these herbal dietary
supplements are effective weight-loss aids.28 Nutritionists “fret that Americans
regard herbs as harmless, no matter what the dose.”29
Due to a lack of consumer education and/or misleading advertising, many
Americans using dietary supplements falsely believe that the FDA, Federal Trade
Commission (FTC),30 or some other governmental agency will be their watchdog,
disallowing any harmful supplements or ingredients.31 This is simply not true.
Dietary supplements do not go through the strict screening that drugs must go
through.32 Prescription and over-the-counter drug manufacturers must conduct
studies on safety and effectiveness before the FDA approves a new drug for sale.33
Dietary supplement manufacturers only need to demonstrate that a product is safe
when taken according to the recommended dosage.34 In fact, the FDA does not have
the power to intervene to stop the sale of a supplement unless it poses an
unreasonable risk to health or is marketed as a drug.35
The Federal Food, Drug, and Cosmetic Act (FDCA)36 defines drugs as “articles
intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease
in man or any other animals” and “articles (other than food) intended to affect the
structure or any function of the body of man or other animals.”37 Furthermore, the

<http://www.fda.gov/bbs/topics/NEWS/NEW00591.html>; MAYO CLINIC, FDA Warns
Against “Herbal Fen-Phen,” (Nov. 13, 1997) <http://www.mayohealth.org/mayo/
9711/htm/fen-phen.htm>.
27

FDA Cracks Down on ‘Herbal Fen-Phen’ and Warns Consumers, WALL ST. J., Nov. 7,
1997, available in 1997 WL-WSJ 14173035.
28

Bob Condor, It’s a Jungle: Herbal Weight-Loss Concoctions Have Risks, But No
Guarantees, CHI. TRIB., Feb. 25, 1998, available in 1998 WL 2829053.
29

Id.

30

See generally Douglas W. Hyman, Esq., The Regulation of Health Claims in Food
Advertising: Have the FTC and the FDA Finally Reached a Common Ground?, 51 FOOD AND
DRUG L.J. 191 (1996).
31

Condor, supra note 28.

32

Pub. L. No. 103-417, § 6, 108 Stat. at 4329 (codified at 21 U.S.C. § 343(r)(6) (guidelines
for making supplements available only assert requirements about statements of nutritional
support)).
33

FDCA, 21 U.S.C. § 321(p); Herbal Hope or Herbal Hype?, supra note 11.

34
DSHEA § 4(f)(1)(A), (B); Martha Schindler, Navigating the Natural Sports
Supplements, NAT. HEALTH, May 15, 1998, available in 1998 WL 9870616.
35

DSHEA, § 4(f)(1)(A); Herbal Hope or Herbal Hype?, supra note 11.

36

Pub. L. No. 75-717, 52 Stat. 1040 (1938) (codified as amended 21 U.S.C. § 301 et seq.).

37

Id. (codified at 21 U.S.C. § 321(g)(1)(B),(C)).
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FDCA, as amended by the DSHEA, regulates supplements as “foods” and not
“drugs,” specifically prohibiting dietary supplements from making drug claims.38
Moreover, critics warn that supplements are regulated as foods but used as
drugs.39 Companies that market or imply weight-loss benefits by imitating
prescription drug names are violating federal law and must be stopped.40 Products
like these may run the risk of being classified as new drugs, requiring FDA approval
before sale.41 The FDA, using the powers designated by the DSHEA to its Secretary,
should promptly act to change the current availability of such products to avoid
catastrophic health problems.42
Another governmental agency, the FTC, has a regulating hand in the supplement
industry and this agency works closely with the FDA and monitoring advertising for
supplements.43 One example of the FTC's exercise of regulatory dominion occurred
in 1997 after the FTC launched a consumer education and regulatory campaign,
“operation waistline.”44 Because of this campaign, the FTC engaged in settlement
agreements with some supplement manufacturers, prohibiting future advertising that
lacks appropriate claim substantiation and trustworthy scientific data.45 The
disingenuous claims made in several products' ads included:
(1)NEW ALL-NATURAL WEIGHT LOSS PRODUCT, NOW ON THE
MARKET! If you've heard about the new 'Phen/Fen' Diet, and thought
about trying it . . . . Don't! With the ALL NATURAL 'Thin-Thin Diet,'
you can achieve the same results, without the dangerous side-effect of
Drugs! Eat the foods you want, and STILL lose 10-12 pounds per
month!;
(2) Neuro-Thin turns your ‘hunger switch’ off; and
(3) Neuro-Thin help[s] balance the levels of serotonin and dopamine in
your brain. The result? Food cravings and hunger pangs are eliminated
. . . and . . . you'll be on your way to achieving your goal.46
Because these advertisements make claims based on studies that were not performed
on humans, they seem insufficient according to the DSHEA’s standard that requires

38
Pub. L. No. 103-417, § 3, 108 Stat. at 4327 (codified at 21 U.S.C. § 321 (ff)(1)). Robert
G. Pinco & Paul D. Rubin, Ambiguities of the Dietary Supplement Health and Education Act
of 1994, 51 FOOD & DRUG L.J. 383, 390 (1996).
39

Kassel, supra note 14, at 268.

40

U.S. Government Warns Consumers About ‘Fen-Phen’ Substitutes, supra note 8.

41

Id.

42

Pub. L. No. 103-417, § 4, 108 Stat. at 4328 (codified at 21 U.S.C. § 342(f)(1), (2)).

43

See generally Hyman, supra note 31.

44

TrendMark Thin-Thin Diet Program Weight Loss Claims Lack Substantiation, supra
note 6.
45

Id.

46

Id. (emphasis in original) (the only substantiation offered for these powerful claims was
based on studies performed on rats and in test tubes).
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“reasonable assurances” of a new product's safety.47 According to Food Science and
Human Nutrition Specialist, Pat Kendall, Ph.D., R.D., at Colorado State University,
another alarming truth associated with inadequate regulation is that unrestricted
“[f]actors, such as variations in growth, product preparation, and storage length and
conditions, affect the quality and potency of a product. In addition, plants are
sometimes improperly identified by manufacturers.”48 Consequently, illustrations of
the need for regulatory changes are plentiful; a look at FDA records revealed over
2,500 reports of side effects and 79 deaths associated with dietary supplement use.49
Primarily due to a lack of consumer education and reliance upon government for
proactive intervention, the FDA is working to regain more power to protect the
public's health.50 On April 29, 1998, the FDA proposed changes to the current
regulatory scheme, hoping to better protect the health of Americans.51 Until these
proposals are approved, the FDA can only regulate with minimal effect under the
DSHEA.52
III. CURRENT REGULATIONS UNDER THE DIETARY SUPPLEMENT HEALTH AND
EDUCATION ACT OF 1994
In response to tremendous quantities of mail, phone calls, and constituent
pressure, Congress enacted the Dietary Supplement Health and Education Act
(DSHEA), “reduc[ing] the regulatory burdens on dietary supplement
manufacturers.”53 Some call the DSHEA “a compromise” because neither the
supplement manufacturers nor increased regulation advocates, like the FDA, gained
more coveted reformations than the other.54 In practice, the DSHEA has proven to
be problematic and has allowed dangerous supplements to remain on the market.55

47

Pub. L. No. 103-417, § 4, 108 Stat. at 4328 (codified at 21 U.S.C. § 342(f)(1)(B)).

48

Kendall, supra note 12.

49

Rebecca Porter, Supplements Supply Dietary Danger, as FDA Looks on, 34 TRIAL 12, 12
(1998).
50
Regulations on Statements Made for Dietary Supplements Concerning the Effect of the
Product on the Structure or Function of the Body, 63 Fed. Reg. 23,623 (1998) (to be codified
at 21 C.F.R. pt. 101) (the FDA proposed regulations that will define the types of statements
that may be made on supplements. This initiative was in response to the Commission on
Dietary Supplement Labels’ report and to offer guidance for the industry as a whole).
51

Id.; see generally Dietary Supplements Containing Ephedrine Alkaloids.

52

See discussion infra Parts III, IV.B.

53

Steven H. McNamara, FDA Regulation of Ingredients in Dietary Supplements After
Passage of the Dietary Supplement Health and Education Act of 1994: An Update, 51 FOOD &
DRUG L.J. 313 (1996). Within a three-year period, Congress experienced more pressure on
this issue than health care reform, abortion, or the deficit. Id.; see also FDA Take on Vitamins
Raises Concerns, PLAIN DEALER (Cleveland), Nov. 28, 1993, available in 1993 WL 5103381.
54
McNamara, supra note 57, at 313; Michael F. Conlan, Supplement Settlement: Both
Sides Hail Compromise in a Vitamin Duel as Victory, DRUG TOPICS, Nov. 7, 1994, available
in 1994 WL 2886154.
55

See supra notes 46-50 and accompanying text.
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Signed by the President in October of 1994, the DSHEA amended the Federal
Food, Drug, and Cosmetic Act (FDCA), primarily affecting dietary supplements and
their dietary ingredients.56 Public health and welfare were at the forefront of
Congress' intentions with the enactment of the DSHEA.57 Additionally, Congress
recognized that, “millions of consumers believe dietary supplements may help to
augment daily diets and provide health benefits.”58 To advance these goals, the
DSHEA was designed to satisfy both consumers and manufactures by keeping safe,
properly labeled products available to those seeking them.59 Among the findings
made in relation to the DSHEA, Congress confirmed that “there may be a positive
relationship between sound dietary practice and good health, and that, although
further scientific research is needed there may be a connection between dietary
supplement use, reduced health-care expenses, and disease prevention.”60
Before the passage of the DSHEA, pre-market safety evaluations, required by the
FDCA, ensured that dietary supplements available to consumers were safe, providing
labels that were direct, not misleading, for consumers to readily understand.61 The
DSHEA changed all this, allowing dietary supplement manufacturers to introduce
new supplements without the FDA’s prior approval.62 Manufacturers are no longer
required to submit safety and efficacy reports to the FDA for prior approval and
herbal products may be introduced without standardized dosages or strengths.63
Section 4 of the DSHEA discusses dietary supplement safety requirements.64
While preserving adulteration standards set out by the FDCA, the DSHEA does
create two additional standards.65 A supplement or dietary ingredient is adulterated
if it “presents a significant or unreasonable risk of illness or injury under conditions
of use recommended or suggested in labeling, or if no conditions of use are
suggested or recommended in the labeling, under ordinary conditions of use.”66

56

Pub. L. No. 103-417, § 3, 108 Stat. at 4327 (codified at 21 U.S.C. § 321(a),(ff)); FOOD
DRUG ADMINISTRATION, Dietary Supplement Health and Education Act of 1994, (Dec. 1,
1995) <http://vm.cfsan.fda.gov/~dms/dietsupp.html> [hereinafter FDA, DSHEA].
AND

57

§ 2, 108 Stat. at 4325 (codified at 21 U.S.C. § 321 NOTE (1)).

58

FDA, DSHEA, supra note 56.

59

Pub. L. No. 103-417, § 2, 108 Stat. at 4325 (codified at 21 U.S.C. § 321 NOTE (2));
FDA, DSHEA, supra note 56.
60

FDA, DSHEA, supra note 56.

61

Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 321 (1993); FDA, DSHEA, supra
note 56.
62

Pub. L. No. 103-417, §§ 6, 7, 108 Stat. at 4329 (codified at 21 U.S.C. § 343(r)(s)); FDA,
DSHEA, supra note 60.
63

Herbal Hope or Herbal Hype?, supra note 11. But cf. infra notes 72-74 and
accompanying text; Pub. L. No. 103-417, § 4, 108 Stat. at 4328 (codified at 21 U.S.C.
§ 342(f)(1)(A)) (showing that limited safeguards still exist).
64

DSHEA, Pub. L. No. 103-417, § 4, 108 Stat. 4325, 4328 (codified at 21 U.S.C. 342).

65

Id. at 4328 (codified at 21 U.S.C. 342(f)(1)(A)).

66

Id.
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Under either of the above stated conditions, the Secretary may conclude that the
supplement poses an imminent hazard to health and/or safety of the public.67
Additionally, the DSHEA created a new category, separate from food or drugs, to
include any “dietary supplement for use by man to supplement the diet,”68 it
redefines a “dietary supplement” as a product (excluding tobacco) meant to fortify
the diet.69 According to the Act, a supplement also includes a product that
bears or contains one or more of the following dietary ingredients: a
vitamin; a mineral; an herb or other botanical; an amino acid; a dietary
substance for use by man to supplement the diet by increasing the total
dietary intake; or a concentrate, metabolite, constituent, extract, or
combination of any ingredient[s listed above.]70
A dietary supplement intended for ingestion may come in various forms, including a
pill, capsule, tablet, or liquid form.71 Consequently, the definition of a dietary
supplement has been expanded. These relaxed standards enabled manufacturers to
market various supplements that have proven to be less than safe.72 Although
Congress' intent with the passage of the DSHEA was noble,73 the ramifications
following its passage render the DSHEA less than commendable.74
IV. VITAL REGULATORY LEGISLATION PRECEDING THE DIETARY SUPPLEMENT
HEALTH AND EDUCATION ACT OF 1994
A. Federal Food, Drug, and Cosmetic Act of 1938
Since its introduction in 1938, the Federal Food, Drug, and Cosmetic Act has had
a significant effect upon the vitamin and dietary supplement industry.75 Through this
Act, the FDA received authorization to proctor foods and dietary supplements,
monitoring safety and truthfulness in labeling.76 Currently, the FDCA is still in
effect as amended by the DSHEA and it remains the leading legislative tool for
regulating foods, drugs, and dietary supplements.

67

Id. (codified at 21 U.S.C. § 342 (f)(1)(C)).

68

Pub. L. No. 103-417, § 3, 108 Stat. at 4327 (codified at 21 U.S.C. § 321(ff)(1)).

69

Id.

70

Id.

71

Id; FDA, DSHEA, supra note 56.

72

See supra note 46 and accompanying text and infra note 106 and accompanying text.

73

Pub. L. No. 103-417, § 2, 108 Stat. 4325 (codified at 21 U.S.C. § 341 NOTE (1),(2)).

74

See supra Part III.

75

See generally Kathi Gannon, Vitamin Showdown: Who Should Control Dietary
Supplements?, DRUG TOPICS, Jan. 24, 1994, available in 1994 WL 2886032.
76
Id. The FDA, under the FDCA, commenced actions against many dietary supplement
ingredients, including St. John’s Wort, to confirm whether the ingredients were illegal because
they failed to meet “food additive” standards. McNamara, supra note 53, at 315-16.
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B. Nutrition Labeling and Education Act of 1990
By enacting the Nutrition Labeling and Education Act of 1990,77 Congress
amended the FDCA and gave the FDA the power to require that foods and, later
through amendment, supplement labels making nutritional or disease-related claims
must be backed by sound scientific data.78 This Act brought herbs and similar
nutritional substances within the scope of the dietary supplement definition.79
After this Act was passed, consumers flooded the FDA and Congress with letters
fearing the implementation of this law.80 Others voiced concern that supplements
would be removed from stores or only available with a doctor's prescription.81 FDA
officials tried to dispel these false beliefs and reassure consumers that products
would not be removed but relabeled if necessary.82
C. Dietary Supplement Act of 1992
Opposition to the Nutrition Labeling and Education Act of 1990 (NLEA) gave
rise to the Dietary Supplement Act of 1992, which made a one-year moratorium
possible.83 Consumer groups and the supplement industry put forth a strong effort to
influence Congress to stop the NLEA’s implementation.84 The moratorium
temporarily halted the FDA's regulation of dietary supplements under the NLEA.85
Soon after, the lenient DSHEA was enacted, which continued to limit the FDA’s
protective powers because it was too easy on supplement standards.
V. DEADLY AND INEFFECTIVE DIETARY INGREDIENTS IN
“HERBAL FEN-PHEN” PRODUCTS
Herbal fen-phen products primarily combine dietary ingredients including:
Ephedrine, St. John's Wort, and sometimes 5-hydroxy tryptophan or caffeine.86 As
repeatedly proven by adverse medical reactions, these are unsafe mixtures.87

77

Pub. L. No. 101-535, 104 Stat. 2353 (1990) (codified at 21 U.S.C. 343 § 403).

78

Id.; see also Gannon, supra note 75.

79

Pub. L. No. 101-535, 104 Stat. 2353; see also FDA, DSHEA, supra note 56.

80

Gannon, supra note 75.

81
Id. These fears were “spurred on by some makers of dietary supplements who are
waging an all-out campaign, with brochures and handouts, telling consumers they can ‘kiss
their supplements good-bye’ if the FDA is given jurisdiction over them.” Id.
82

Id. (according to an FDA spokesperson).

83

Pub. L. No. 102-571, 106 Stat. 4500 (1992) (codified at 21 U.S.C. § 343).

84

Gannon, supra note 75.

85

Pub. L. No. 102-571, 106 Stat. 4500 (1992) (codified at 21 U.S.C. § 343).

86

Scientific Evidence Suggests the Use of Supplements Such as Phen-Free May Help
Reinforce the Metabolic Rate, (visited Jan. 19, 1999) <http://eas.com/q-a/index.html>.
87
See infra text accompanying note 106; see also Schlendorf v. Alternative Health
Research, Inc., No. 3:97-CV. 104 RV (SMA N.D. Fla. settled May 20, 1998) (herbal
containing ephedra caused a fatal cardiac arrhythmia in a college student).
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Ephedra, also popularly know as ephedrine and ma huang, is notorious for it's
dangerous side effects which include high blood pressure, insomnia, stroke, and even
death.88 Metabolic stimulants, like ephedrine, are fast acting but risky; they suppress
appetite and burn calories by causing an “adrenaline-like effect” on the nervous
system.89 Admittedly, the FDA has acknowledged that is has no reports of side
effects from St. John's Wort.90 However, it strongly cautions consumers that neither
St. John's Wort nor 5-hydroxy tryptophan has been properly studied, and warns that
5-hydroxy tryptophan was related to a supplement banned in the 1990s after it was
linked to a fatal blood disorder.91
A. Ephedra or Ephedrine
“Primarily a bronchial decongestant, ephedra is one of the oldest-known
medicinal herbs.”92 In the 1940s, Ephedrine, the active ingredient in ephedra, began
to be used in the treatment of asthma.93 As the uses of the supplement expanded,
serious side effects were discovered.94 While ephedrine expands breathing passages,
it also constricts blood vessels (vasoconstriction) and increases arterial blood
pressure, leading to severe hypertension, heart attack, or stroke.95 Because of these
side effects, many doctors and pharmacists frowned upon its “single-component”
use96 and refrained from prescribing or recommending it.97 Ephedrine's revival came
with dietary supplement manufactures’ claims of curbed appetite, increased energy,
and a faster metabolism.98 Research has proven that ephedra contains the alkaloid
ephedrine, a natural central nervous system stimulant.99

88
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, FDA Proposes Safety Measures
for
Ephedrine
Dietary
Supplements,
HHS
NEWS,
(June
2,
1997)
<http://www.fda.gov/bbs/topics/NEWS/NEW00568.html>; see also Dietary Supplements
Containing Ephedrine Alkaloids, 62 Fed. Reg. 30, 667, 30, 678 (1997) (to be codified at 21
C.F.R. pt. 111).
89

Laurie Berger, The Lowdown on Natural Fat Fighters, VEGETARIAN TIMES, Jan. 1, 1998,
available in 1998 WL 10570594.
90

FDA Cracks Down on ‘Herbal Fen-Phen’ and Warns Consumers, supra note 27.

91

Id.; Sayre v. General Nutrition Corp., 867 F. Supp 431, 435 (S.D.W. Va. 1994) aff'd, 67
F.3d 296 (4th Cir. 1995).
92

Berger, supra note 89.

93

Jody L. Aaron, Death Over-the-Counter: Dangers of Ephedrine, 33 TRIAL 61, 61-62
(1997).
94

Id. at 62.

95

Id.

96

Id. at 62.

97

Id.

98

Aaron, supra note 95, at 62; Schindler, supra note 34.

99

Schindler, supra note 34.
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Since 1993, the FDA has received nearly 1000 complaints about herbal and
synthetic ephedrine products.100 As even more cause for alarm, forty-two deaths
reported to the FDA were connected to ephedrine use.101 The FDA has issued
warnings about the use of ephedra-containing and herbal fen-phen products.102 Sales
of the product have greatly risen in the past ten years, due to the herb's vast
availability because manufacturers have inundated the market with countless
products containing the herb.103 An FDA spokesperson remarked that these were the
most complaints received about any dietary supplement on the market.104 Very few
people using this supplement are aware of its dangers.105 Consider the following
examples of people harmed and even killed from ephedrine products:
(1) A 19-year-old college student begins to take an over-the-counter
ephedrine product he bought as a stay-awake aid from the gas station
where he works. After taking four caplets over a 24-hour period, he dies
while pumping gas. The death, according to the autopsy, was caused by a
massive heart attack triggered by ephedrine toxicity[;]
(2) A 17-year-old high school football player suffers a fatal heart attack
just before going to sleep one evening. According to the autopsy, the
cause was ephedrine toxicity. His use of the product never exceeded the
recommended dosage[; and]
(3) A 16-year-old high school student begins using an ephedrine-based
product as a diuretic. Shortly after taking the pills, she suffers severe
heart palpitations and collapses during a school sporting event. She
continues to require treatment for irregular heartbeat years after the
incident.106
Clearly illustrated by the incidents above, serious health consequences may occur
from ephedrine use, especially if the supplement is misused.107 Additionally,
ephedrine has a half-life between six to ten hours and with repeated use, it can build
to toxic levels in the body.108 Therefore, combining it with other caffeine-containing
products like "coffee, chocolate, or [over-the-counter] pain relief drugs such as

100

Berger, supra note 89.

101

Id.

102

FDA Warns, supra note 2.

103

Aaron, supra note 93, at 62.

104

Berger, supra note 89.

105

Aaron, supra note 93, at 61.

106

Id. (quotations omitted).

107

Schindler, supra note 34. (“Many consumers take a handful of supplements at a time,
yet no one knows how these supplements interact with one another or how they affect the
body’s production of substances such as hormones.”).
108

Aaron, supra note 93, at 62.
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Excedrin can further amplify the [herb's] effect."109 Some herbal fen-phen products
contain caffeine in addition to ephedrine, increasing the hazard for dieters.110
Naturopathic physician and licensed acupuncturist, Ian D. Bier, N.D., L.Ac. does not
recommend this matching of stimulant with stimulant.111 Furthermore, Bier refrains
from recommending or approving the use of either caffeine or ephedra to those
looking to lose weight.112
Adverse reports from consumers and health care providers, and scientific
literature prompted the FDA to propose regulations to provide maximum dosages for
the herb.113 The proposed regulation recommends that ephedrine containing products
be: (1) limited to twenty-four mg per day; (2) banned if combined with stimulants or
caffeine; (3) labeled with the warning, ‘“taking more than the recommended serving
may result in heart attack, stroke, seizure, or death;’” and (4) prohibited from being
marketed for weight-loss or bodybuilding ephedrine supplements.114 Currently some
herbal fen-phen products exceed twenty-four milligrams of ephedrine (some contain
much more).115
These efforts are much needed to protect consumers, often times from their own
actions.116 Although many patients do not take their prescription medications for the
entire time recommended, herbal supplement users are taking these products for long
periods.117 This is a major cause for concern by health care professionals because
this may certainly prove detrimental to individuals' health.118
B. St. John's Wort
In addition to dangerous ephedrine, many herbal fen-phen products also contain
St. John's Wort.119 This ingredient's herbal name is “hypericum perforatum”120 and it
is commonly called “herbal Prozac.”121 Although the herb has been used in many

109

Id.

110

See generally id.

111

Schindler, supra note 34.

112

Id.

113

Porter, supra note 49, at 12; Brenneman, supra note 25.

114

Porter, supra note 49, at 12; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, supra
note 88; Dietary Supplements Containing Ephedrine Alkaloids, 62 Fed. Reg. 30,667, 30,678
(1997) (to be codified at 21 C.F.R. pt. 111); see Kendall, supra note 12.
115

Kendall, supra note 12.

116

See discussion supra note 107 and accompanying text.

117

Brenneman, supra note 25.

118

Id.

119

FDA Warns, supra note 2; MAYO CLINIC, supra note 26; Kendall, supra note 12.

120

This plant, growing in the wild, enhances serotonin, norepinephrine, and dopamine.
LeMonick et al., supra note 2.
121

FDA Warns, supra note 2.

120
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countries to treat mild depression or mood disorders,122 it has not been carefully
studied individually or in combination with ephedrine. 123 The Mayo Clinic reported
that the National Institute of Health will study St. John’s Wort for the first time in the
United States; however, the study will focus on its use for the possible treatment of
depression, not obesity.124
Some experts maintain that St. John’s Wort “mimics the metabolic effects of
ephedra.”125 Consequently, the herb is also used in some ephedra-free diet
products.126 Furthermore, many herbal fen-phen products have both dietary
ingredients; such a composition may equate to the stimulant matching cautioned
against earlier in this Note.127 Scientific studies and research have not proven St.
John’s Wort to be an effective diet aid.128 Moreover, one expert on herbs contends
that “hypericin” has been proven to cause photosensitivity, including dermatitis and
inflammation of mucous membranes when directly exposed to the sun.129
C. 5-Hydroxy Tryptophan
Other herbal fen-phen products include 5-hydroxy-tryptophan among their
dietary ingredients.130 This ingredient also has not been proven effective in
controlled studies.131 In fact, FDA and Mayo Clinic scientists recently confirmed
that the supplement contains impurities.132
Moreover, 5-hydroxy-tryptophan has frequently been associated with Ltryptophan.133 L-tryptophan was removed from the market after a contaminated
batch may have caused eosinophilia-myalgia syndrome (EMS), a rare blood
disorder.134 In more than 1,500 instances L-tryptophan use (as a sleep aid, appetite
suppressant, or menstrual cramp reliever) was linked to EMS.135 In addition, as

122

MAYO CLINIC, supra note 26.

123

FDA Warns, supra note 2.

124

MAYO CLINIC, supra note 26.

125

Berger, supra note 89.

126

Id.

127

See supra notes 111-12 and accompanying text.

128

Berger, supra note 89.

129

Kendall, supra note 12 (citing Varro Tyler, The Honest Herbal).

130

FDA Warns, supra note 2.

131

FDA Cracks Down on ‘Herbal Fen-Phen’ and Warns Consumers, supra note 15.

132

FOOD AND DRUG ADMINISTRATION, Impurities Confirmed in Dietary Supplement 5Hydroxy-L-Tryptophan,
FDA
TALK
PAPER,
(Aug.
31,
1998)
<http://fda.gov/bbs/topics/ANSWERS/ANS00891.html>. The specific impurity, formerly
linked to dangers of L-tryptophan use, is “peak x.” Id.
133

Id.

134

FDA Warns, supra note 2.

135

Id.; Kassel, supra note 14, at 241-42.
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many as thirty-eight deaths were related to EMS and L-tryptophan.136 The Ltryptophan scandal revealed, via victim testimony before Congress, that consumers
assumed that the FDA monitored this product.137
D. PRESCRIPTION “FEN PHEN” V. “HERBAL FEN-PHEN”
As recent as 1997, those who did visit their doctors to obtain weight-loss advice
may have been introduced to this diet miracle in a prescription bottle,138 the nowbanned combination of fenfluramine139 and phentermine,140 commonly known a “fenphen.”141 Separately, the drugs were approved for short-term use by obese
individuals.142 Reports reveal that eighteen million people used the combination
before it was removed from the market.143 “Alone, neither drug (available for nearly
three decades) was doing much to satisfy dieters. The ‘magic’ came as a pairing.”144
One dieter was delighted to experience this “magic” because after years of
unsuccessful dieting, Beth Herwig, 5’4,” weighed more than 500 pounds at the age
of twenty-nine.145 Fen-Phen was prescribed for Beth and she saw great results as her
weight dropped to 265 pounds.146
A combination of two separately approved prescription drugs equates to an offlabel use.147 The FDA does not approve such usage.148 Critics note that “many

136

FDA Warns, supra note 2.

137

H.R. Doc. No. 25 (1991). In Sayre, the plaintiff continually used L-tryptophan to help
her sleep, despite her adverse symptoms and warnings in television and magazine news reports
urging consumers to stop taking the supplements. Sayre v. General Nutrition Corp. 867 F.
Supp. 431, 435, 432-33 (S.D.W.V. 1994) aff’d 67 F.3d 296 (4th Cir. 1995). She continued to
self-medicate before consulting a doctor, at which time she was told that her L-tryptophan use
was causing her symptoms. Id. at 434 ( the court upheld summary judgment for Defendant
because Plaintiff should have known of dangers of harmful product due to sufficient warnings
and information disseminated.). This suit further evidences the lack of caution consumers'
express regarding dietary supplement use. Id.
138
A European weight-loss drug that affects serotonin and dopamine levels. LeMonick et
al., supra note 2.
139

An amphetamine-like drug that increases alertness and helps burn calories faster by
boosting the metabolic rate. LeMonick et al., supra note 2.
140

Doctors combined fenfluramine and phentermine to speed up the metabolism and
provide energy because fenfluramine alone caused drowsiness. LeMonick et al., supra note 2.
141
FOOD AND DRUG ADMINISTRATION, Mixing Diet Drugs Calls for Caution, FDA
CONSUMER MAG., (Sept.-Oct. 1997) <http://vm.cfsan.fda.gov /~dms/fdsupp.html>.
142

Berger, supra note 89.

143

Id.

144

Condor, supra note 28.

145

Id.

146

Id. (Beth implies that fen-phen helped her lose weight and change her attitude towards
food: “It’s not that I don’t want that Twinkie still. . . [b]ut before, I would see it, and there was
almost nothing that could stop me.”).
147

Id.
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doctors went overboard, giving Redux and fen/phen to patients who were merely
overweight, not obese, a violation of the FDA and drug-company prescription
criteria.”149
Before numerous reports documenting heart valve abnormalities potentially
leading to cardiac weakness and even death,150 consumers experienced “short-term
diet miracles” from taking the combination; however, the long-term expense to users
was tremendous.151 Doctors performed echocardiograms152 on patients using the two
drugs simultaneously and found abnormalities in about thirty percent of patients.153
Ironically, patients tested exhibited no other symptoms of heart abnormalities.154
Such substantial reports of heart valve damage and weakened heart muscle from the
drug combination prompted the FDA to recommend removal of the products from
the market.155
In October of 1999, attorneys for the diet-drug users achieved a proposed
settlement with the drug manufacturer for $3.75 billion.156 This products liability,
class action was settled on behalf of people who claimed injuries associated with fen-

148

Id. (see for a discussion, strongly criticizing the two component drugs individually.
Furthermore, research prior to fen-phen’s combination, showed that the FDA and drug
manufacturers know of other serious side effects; however, justifications offered by fen-phen
proponents stressed that disadvantages were outweighed by the benefits); see supra text
accompanying note 1.
149

LeMonick et al., supra note 2 and accompanying text.

150

Condor, supra note 28.

151
A diagnostic procedure to test the functioning of the heart valves. U.S DEPARTMENT OF
HEALTH AND HUMAN SERVICES, supra note 26.
152

U.S DEPARTMENT OF HEALTH AND HUMAN SERVICES, supra note 26.

153

Id.

154

Id. (Mayo Clinic and Mayo Foundation researchers reported 24 cases of rare valvular
disease found in women who took the fen-phen combination therapy.); see generally U.S.
DEPARTMENT OF HEALTH AND HUMAN SERVICES, Interim Recommendations Issued for Patients
Exposed to Fenfluramine and Dexfenfluramine, HHS NEWS, (Nov. 13 1997) <http://www.fda.
gov/bbs/topics/NEWS/NEW00598.html>.
155
U.S DEPARTMENT OF HEALTH AND HUMAN SERVICES, supra note 154. After the drugs
were pulled from the market, many dieters who had been using fen-phen gained the weight
back. Id. The justification for this is simple, the drugs did not cure the underlying cause of
the excess weight. Berger, supra note 89. Aside from over eating, weight gain may be
attributed to underactive thyroids, toxic livers, poor immune systems, or even psychological
afflictions. Id. (“According to the Caloric Control Council, 60 million consumers—or one in
four Americans—are trying to lose weight at any given time. And each year, impatient dieters
ignore doctors’ orders to change their eating habits, preferring to shell out nearly $33 billion
on ‘wonder drugs’ and diet products.”). For all the preceding reasons, herbal weight-loss
remedies are also not the answer or quick-fix which consumers demand. MAYO CLINIC, supra
note 26 (“Beware of any pill that claims it will lead to fast, easy or permanent weight loss.”
(emph. added)).
156

Alicia Mundy, A Big Fat Settlement, U.S. NEWS ONLINE, (Oct. 18, 1999)
<http:www.usnews.com/usnews/issue/991018/fen.htm>.
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phen use.157 The settlement proposal is unique in that it provides for long-term
medical monitoring of people who currently have no symptoms of valvular or lung
disorders but did use the drug pair.158
VI. DISCUSSION AND PROPOSALS
A. Remove Current Herbal Fen-Phen Products Containing Ephedrine from the
Market: Federal & State Actions
The FDA must exercise its power to remove the herbal fen-phen products from
the market;159 however, it has only issued warnings at this point.160 The products,
due to their hazardous ingredient composition, do pose an unreasonable health risk
and may, therefore, be removed promptly.161 Based on drug-like claims162 and the
dangers associated with ephedrine and 5-hydroxy tryptophan,163 the Secretary must
exercise the power to remove these products.164 Also, these products are in violation
of FTC and FDA marketing mandates because the products infer that they are
substitutes for prescription drugs.165 For example, calling St. John’s Wort, “herbal
Prozac,” or anti-obesity supplements, “herbal fen-phen” falsely and dangerously
imply that these products will deliver the same results as prescription drugs.166
Aside from the FDA, individual states may ban or restrict the sale of harmful
herbal fen-phen supplements.167 Approximately fourteen states, including Florida,168
Illinois,169 and Ohio,170 have passed laws to ban or restrict the sale and use of some

157
Id. (the settlement is pending approval by the court and many lawyers have advised
their clients to decline the offered settlement).
158

Id.

159

Porter, supra note 49, at 14.

160

FDA Warns, supra note 2.

161

Pub. L. No. 103-417, § 4, 108 Stat. at 4327 (codified at 21 U.S.C. § 321(f)(1)(B)).

162

FDA Warns, supra note 2.

163

See supra Part V.A.C.

164

Pub. L. No. 103-417, § 2, 108 Stat. at 4326 (codified at 21 U.S.C. § 321 NOTE (12)).

165

Regulations on Statements Made for Dietary Supplements Concerning the Effect of the
Product on the Structure or Function of the Body, 63 Fed. Reg. at 23,623; FDA Warns, supra
note 2; FOOD AND DRUG ADMINISTRATION, FDA's Dietary Supplement Proposal (last modified
Apr. 27 1998) <http://www.fda.gov/bbs/ topics/FACTSHEETS/fs_diet1.html>.
166
Regulations on Statements Made for Dietary Supplements Concerning the Effect of the
Product on the Structure or Function of the Body, 63 Fed. Reg. 23,623; FDA Warns, supra
note 2; FOOD AND DRUG ADMINISTRATION, FDA's Dietary Supplement Proposal (last modified
Apr. 27 1998) <http://www.fda.gov/bbs/ topics/FACTSHEETS/fs_diet1.html>.
167

39 AM. JUR. 2D, Health § 1 (1968); Kurtzweil, supra note 25.

168

Fla. Stat. ch. 499.0054 (1998).

169

720 Ill. Comp. Stat. 570/210 (g)(1) (West 1999).

170

OHIO REV. CODE. ANN. § 3719.41 (West 1998).
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products containing ephedrine due to their proven hazards.171 Florida, for instance,
has banned all ephedrine-containing products unless dispensed by prescription;172
furthermore, individuals found to be “trafficking” ephedrine are charged with a firstdegree felony.173 Illinois has similarly cracked down on ephedrine use, especially by
adolescents.174 In Wilson v. Collinsville Community School District, the court upheld
the school board's expulsion of a student possessing pills combining ephedrine and
caffeine.175 Ohio also classifies Ephedrine as a “Schedule IV” controlled substance
which includes: “any material, compound, mixture, or preparation that contains any
quantity of the . . . substance[] having a stimulant effect on the central nervous
system.176 Unfortunately, many other states have not acted thus far.177
B. Legislative Changes: DSHEA Reforms Are Needed
1. Overview
Even a principal sponsor of the DSHEA, Congressman Bill Richardson, admitted
there was a need to reform the DSHEA.178 Consequently, Richardson proposed to
clarify and possibly repeal the DSHEA.179 Members of the supplement industry were
divided over whether to support Richardson's proposals.180
By enacting new or amending current laws, the Government can provide greater
protection to all dietary supplement consumers,181 especially for those who fail to
sufficiently educate themselves prior to the purchase or ingestion of a supplement
such as herbal fen-phen.182 This Note does not imply that supplements should be
regulated as drugs, requiring a prescription from a physician.183 Instead, supplements
should have to meet more rigorous safety and efficacy standards before being

171
Kurtzweil, supra note 25; Bruce A. Silverglade, Regulating Dietary Supplements Safety
Under the Dietary Supplement Health and Education Act: Brave New World or Pyrrhic
Victory?, 51 FOOD & DRUG L.J. 319 (1996); Aaron, supra note 93, at 62.
172

Fla. Stat. ch. 490.033(1) (1998).

173

Id. at ch. 893.135(f)(1).

174

See generally Wilson v. Collinsville Community Unit Sch. Dist., 451 N.E.2d 939 (5th
Cir. Ill. 1983).
175

Id.

176

OHIO REV. CODE. ANN. § 3719.41 Schedule IV (C)(1).

177

See Tod L. Stewart, Case Note, Getting High with a Little Help from the Feds: Federal
Regulation of Herbal Stimulants, 6 J. PHARMACY & L. 101, 109-113 (1997).
178

Silverglade, supra note 171, at 320.

179

Id. at 319 n.3. (citing H.R. 1951, 104th Cong. (1995)).

180

Id. at 319.

181

39 AM. JUR 2D, Health § 1 (1968).

182

Pub. L. No. 103-417, § 2, 108 Stat. at 4326 (codified at 21 U.S.C. § 321 NOTE
(8),(10)).
183

Silverglade, supra note 171, at 319.
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released. Before the deregulation under the DSHEA, manufacturers were required to
make such showings under the FDCA.184
Additionally, an improved regulatory scheme should require the establishment of
purity levels for ingredients to guarantee consistency and improve safety in
supplements because they are not regulated for potency or quality.185 Essentially,
“[h]erbal remedies have a place in wellness and healthcare. They also need to be
regulated to ensure safety, quality, potency and appropriate use.”186 One example of
these inconsistent factors may be found in St. John’s Wort.187 One manufacturer’s
product may contain dried flowers from the herb, while another may use a liquid
extract.188 The problem is that we cannot tell how much of the “active ingredient, if
any” we are ingesting.189
The problem is exacerbated by the fact that herbal supplements are no longer
confined to small, remotely located health food stores.190 Supplements are now
frequently found in supermarket aisles and pharmacies,191 retail outlets in malls and
plazas, on television, in catalogs, and on-line.192
2. Restore FDA's Power to Serve and Protect: Increase Funding
Because the FDA has limited resources, it focuses on public health emergencies
and products that have caused injury and/or illness receive analytical attention before
fraudulent or illegal products.193 Currently, funding of the FDA is inadequate to
allow necessary practices of protecting consumers to expand.194 For example, if a
concerned consumer contacts the FDA for information about the concentration or
amount of a dietary ingredient per serving, their request is denied due to a lack of

184

21 U.S.C. § 321(g) (defining a “drug”).

185

Porter, supra note 49, at 12.
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Kendall, supra note 12.

187

Herbal Hope or Herbal Hype?, supra note 11.

188

Id.
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Id.

190

Brenneman, supra note 25.

191

According to Hunter Pelley, R.Ph., Pharm.D: ‘“Weight-loss aids are among our best
sellers and herbal fen-phen is the best selling natural weight-loss product we stock. The St.
John’s wort and ephedra combination is popular.”’ Judith Eaten, M.S., R.D., C.N.D., Beyond
Fen-Phen: What's Safe in Weight Loss Products, NAT. PHARMACY, (Feb. 1998)
<http://www.healthshoppe.com/hl_womenshealth_diet.htm> (quoting Hunter Pelley, R.Ph.,
Pharm.D.).
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Brenneman, supra note 25; Supermarkets Experience Fastest Rate of Growth in
Mainstream Dietary Supplement Market, NAT. BUS., (Oct. 1998) reprinted in Herb World
News Online <http://www.herbnet.com>.
193
FOOD AND DRUG ADMINISTRATION, Overview of Dietary Supplements, (May 1997)
<http://www.vm.cfsan.fda.gov/~dsm/ds-oview.html> [hereinafter Overview of Dietary
Supplements].
194

Id.
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monetary resources.195 Instead consumers must rely either on biased manufacturers
for detailed information beyond ads and labels, or hire an independent laboratory for
a costly analysis.196 These are simple, yet effective, practices that the FDA could
adopt to better serve Americans if Congress would authorize increased, necessary
funding.197
Increasing funding for committees appointed by legislative enactment would
allow such groups to do work that is more effective.198 Currently, the Office of
Dietary Supplements only receives $5,000,000 to run an entire division charged with
the monumental task of improving the way supplements are regulated and provided
to the public.199 Funding for such vital groups should be in proportion to the huge
success of this booming industry.200 In Germany, a special governmental committee,
"Commission E," is maintained for the sole purpose of regulating herbal products.201
Germany provides a model that the government should use as a guide for future
reformations.
3. Manufactures' Contributions
Along with stronger legislation, manufactures should be responsible to provide
an abundant amount of clear and accurate information to consumers with the sale of

195

Id.

196

Id.

197

See generally id.

198

See generally Kurtzweil, supra note 25.

199

Pub. L. No. 103-417, § 485C, 108 Stat. at 4334 (codified at 42 U.S.C. § 287C-11).
Additionally, groups like the Council for Responsible Nutrition, made up of manufactures,
should also increase its monetary contribution to improve American’s health. Pub. L. No.
103-417, § 2, 108 Stat. at 4326 (codified at 21 U.S.C. § 321 NOTE (12) (Congress found that
an estimated 600 supplement manufacturers sold 4,000 products and realized sales of
$4,000,000,000.). This group and others like the Corporate Alliance for Integrative Medicine,
sponsor consumer education efforts to better service consumers. Industry Alliance Formed to
Increase Research and Education on Supplements, BUS. WIRE, (Oct. 8, 1998) reprinted in
Herb World News Online <http://www.herbnet.com>. Manufacturers need to act more
responsibly, avoiding deceptive and dangerous tactics to increase sales. “Since the federal
Food and Drug administration issued warnings on [ephedra, Chaparral and DHEA] in the past
three years, they’re ‘being snuck into’ more than 90 other products in the weight loss, sports
and energy supplement sections.” Brenneman, supra note 25 (quoting nutritionist Mark
Mincolla).
200
Pub. L. No. 103-417, § 2, 108 Stat. at 4326 (codified at 21 U.S.C. § 321 NOTE
(12)(C)).
201

Edgar R. Cataxinos, Note, Regulation of Herbal Medications in the United States:
Germany Provides a Model for Reform, 1995 UTAH L. REV. 561, 579-589 (Cataxinos’ use of
the phrase “herbal medications,” for purposes of this comparison, should be construed to mean
the same as “dietary supplements” referred to in this Note). Germany has enjoyed support
from both the medical and pharmaceutical/supplement companies with regard to safety and
efficacy of supplements. Id. at 578. A good portion of a product’s research is contracted for
or achieved through grants with educational institutions. Id.
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each product.202 This point is especially crucial because "[t]here are no significant
studies to prove the success rate of herbal fen-phen products.”203 Experts suggest
that consumers should request and manufacturers should provide data evidencing
scientific results from product tests.204 Even FDA critics, like Senator Orrin Hatch
and Representative Bill Richardson, “encourage greater consumer knowledge about
preventative medicine.”205 The two legislators, in a joint statement, also remarked:
“It doesn’t make any sense at all to curb the dissemination of information about
products that could end up saving this nation billions of dollars in health-care
costs.”206
Further information should also be made available through toll free phone
numbers or web sights, allowing a consumer to make a more informed decision
about what supplements to use and which to stay away from.207 The “MedWatch”
program, offered by the FDA, enables health care professionals to report harmful
effects or illnesses suffered by patients from dietary supplements.208 Incidents may
be reported to MedWatch via its website, www.fda.gov/medwatch/report/hcp.htm, or
hotline at 1-800-FDA-1088.209 Several manufactures are currently attempting to
service this need through the internet;210 for example, EAS has a web site which
gives information about the company and its products.211 A simple search of this site
will afford consumers facts about a supplement's ingredients, purpose, and dosage.212
Another part of the database, “frequently asked questions” gives visitors satisfactory
responses to inquiries commonly made about various products.213
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Several other responsible manufacturers are attempting to reach out to consumers
by offering them a considerable amount of information.214 For example, Goldine, a
supplement manufacturer, tells consumers what is and what is not in their
supplements.215 They take this “full-disclosure labeling” one step further by giving
informational statements on the labels of each product, telling the consumer why that
supplement is recommended.216 This is a commendable start; however, Americans
need to consistently see more supplements on the shelves with such information.217
Recently, the Council for Responsible Nutrition, an organization of dietary
supplement manufactures and suppliers, submitted “Good Manufacturing Practices
(GPMs)” to the FDA.218 The FDA is reviewing these suggested industry practices
and considering making GMPs mandatory.219 Today about ninety percent of
manufacturers use the Council’s draft of a warning label for ephedrine alkaloidcontaining products.220 This exemplifies the GMPs fostered by most of the
supplement industry; however, any non-compliance remaining must be corrected
through governmental mandate.221 The manufacturers that have not adopted the
warning, in combination with misuse and misguided recommendations, continue to
threaten consumer health.222
C. Significantly Increase Dietary Supplement Research
Another issue to be addressed by future, legislative reform concerns dietary
supplement research. This change is necessary simply because today’s marketing is
too far ahead of research.223 Because human studies to test how various supplements
or ingredients taken simultaneously interact have not been performed for more than a
few weeks at a time, we do not know the long-term health effects of supplement
usage.224 This would require scrutiny of a preponderance of data from scientific
studies of the health benefits conferred upon individuals through dietary supplement
use.225
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In addition, “many consumers take a handful of supplements at a time, yet no one
knows how these supplements interact with one another,” claims Priscilla M.
Clarkson, Ph.D., professor of exercise science at the University of Massachusetts at
Amherst and editor of the International Journal of Sport Nutrition.226 Varying doses
and dietary ingredients may be deteriorating our health rather than helping to
maintain it.227 We have been warned by the tremendous number of adverse
consequences from the use of ephedra; similar or more devastating effects may be
what the future of hold for the majority of herbal fen-phen users.228 We cannot wait
to see if or what may occur, intensive research project on humans, not animals, must
be conducted.229 Ultimately, Congress and the supplement manufacturers should
provide the financial means necessary to conduct such studies.230
D. Training of Health Care Professionals: Dietary Supplement Education for
Physicians
Ideally, “[c]onsumers who use dietary supplements should always read product
labels, follow directions, and heed all warnings.”231 Unfortunately, many consumers
fail to do so. Doctors and health care professionals, however, can help increase
awareness and responsible supplement use.232
Medical doctors need to be better informed about dietary supplements and their
possible interactions with prescription medications.233 Many doctors admit that they
are not trained about supplements and patients do not tell their health care providers
about supplement usage.234 Because many patients who consult a doctor fail to
mention that they use supplements, physicians need more knowledge about
supplements so they may provide better care to patients by asking more informed
questions to gather pertinent information.235
Achieving a broader base of information, through appropriate questions, may
enable doctors to better care for patients by uncovering and addressing supplement
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usage, attempting to dispel misconceptions, and even reporting suspicions about
supplement misuse or interaction to the FDA.236 Moreover, this action would
certainly help combat the present danger of mixing some prescription drugs with
supplements.237
Most importantly, a physician's expert advise that “[l]ong term use of [herbal]
stimulants is not advised because they keep the body in a constant ‘fight or flight’
mode, rapidly depleting its energy reserves and potentially leading to a variety of
disorders” certainly may make a strong impression on patients.238 Altogether, this
justification for expanded physician education is logical and necessary with the rapid
growth of this industry.239
E. Responsible Reporting and Public Service Campaigns
Finally, an increase in the frequency of responsible reports by various media
outlets and public service campaigns could considerably raise consumer
awareness.240 By providing consumers with accurate and scientifically sound
information about safety, and the appropriate use, benefits, and risks of supplements,
education campaigns can significantly impact and improve consumers' usage and
impressions of supplements.241 If Americans are repeatedly warned about potential
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Still today, countless Americans look at themselves in the mirror each day and cringe at
what they see peering back at them. They feel unattractive and unhealthy because they are
carrying excess pounds. Adding to and in some cases creating this complex is society's
endless focus and promotion of healthy eating, exercise, and generally looking great;
altogether, this image conveys one message loud and clear: LOSE WEIGHT AND BE THIN.
CENTER FOR DISEASE CONTROL AND PREVENTION, Statistical Rolodex-Overweight Prevalence
(last modified May 28, 1998) <http://www.cdc.gov/nchswww/fastats/overwt.htm> (studies in
the United States between 1988-1994 revealed that 35% of the adults are overweight).
Consequently many ask: What is a slightly overweight or obese person to do when they
have tried to diet, exercise, and even starve themselves to no avail? See Woman's Death
Raises Questions About Fen-Phen Diet, supra note 1 (obesity is defined as 20% or more over
normal weight; Body mass index of 30 or greater); see also FDA Warns, supra note 2. They
should seek professional help from a physician or nutritionist. The unfortunate reality is that
many individuals can only muster up enough courage to stop into a health food store in the
mall or a diet clinic, or buy products advertised on television or the internet from the privacy
of their own living rooms. Kassel, supra note 14, at 247-48. Emotional appeals by
manufacturers encourage people to use supplements for medical treatment instead of
consulting their physician. Id. These unguided searches for weight-loss shortcuts have proven
to be hazardous to our health. Kendall, supra note 12. Laura Neergaard, Government Cracks
Down on Diet Supplement, (Nov. 6, 1997) <http://www.sddt.com/files/librarywire/9…es/1197/DN97_11_06_fay.html>.
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dangers lurking in certain supplements or through the abuse of supplements, they
may begin to use this information to create a more favorable and healthful system.242
The National Institute of Health (the Institute also maintains the Office of Dietary
Supplements) now sponsors an internet site to provide information to the public as
well as health care providers.243 Currently, the site offers credible information on
dietary supplements from ‘“published, international, [and] scientific literature.’”244
Later, the database will allow users to search for bibliographical data through keywork searches.245 This service is a commendable attempt at dealing with consumer
awareness deficiencies; however, much more is needed to properly address this
serious hurdle.246
The message must be conveyed effectively: “the best way to lose weight is to do
it slowly: [S]witch to a low-fat, sensible diet and get regular exercise.”247 We must
take responsibility to teach the public and better shape younger generations’ attitude
towards health.248 In doing so, we can effectively discourage Americans from
“opt[ing] for the easy way out—fat-free chips, diet soda and a bottle of the latest fatburning pills.”249
VII. CONCLUSION
Currently, manufacturers and distributors have “free reign in testing and
marketing” products as long as they are called a “dietary supplement.”250 Due to
powerful lobbying efforts by the supplement industry, regulatory modifications may
evolve very slowly.251 Nevertheless, we must be optimistic as some supplement
makers are attempting to work with the FDA, striving to better serve consumers.
Amending the DSHEA or enacting more effective, consumer-oriented legislation
would serve to satisfy Congress, consumers, and manufacturers. Moreover,
Congress’ goal of protecting and improving Americans’ health can be made possible
through the implication of the solutions proposed in this Note, while maintaining
consumers’ access to a wide variety of safe dietary supplements. As a result of
modifications to current dietary supplement regulatory practices, as proposed and
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discussed in this part VI of this Note, the supplement industry will enjoy increased
credibility and prosperity as consumers gain confidence in the system.
The legislative alterations and proposals contained in this Note are attainable.
Because Americans’ health and well-being is such a legitimate concern, all parties
need to work together and compromise to achieve these goals. We have all heard the
reoccurring message from health care professionals who advise consumers to:
“[R]ealize that the label term ‘natural’ doesn't guarantee that a product is safe.”252
Take a moment to “‘[t]hink of poisonous mushrooms,’ says Elizabeth Yetley, Ph.D.,
director of FDA’s Office of Special Nutritionals. ‘They’re natural.’”253
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